Biotechnology | Retirement Agreements | Business Contracts

Castle Biosciences, Inc. Retirement Policy Approved January 13, 2023 (CASTLE BIOSCIENCES INC, Filed With SEC on February 28, 2023)

The Registrant's Equity Award, Death, Disability and Retirement Policy (EXACT SCIENCES CORP, Filed With SEC on February 21, 2023)

Fourth Amendment to the Amgen Inc. Supplemental Retirement Plan, effective October 20, 2022 (Amgen Inc., Filed With SEC on February 9, 2023)

Retirement Policy for Equity Awards (Intellia Therapeutics, Inc., Filed With SEC on August 4, 2022)

Retirement and Transition Agreement dated April 19, 2022, between the Company and Laura Clague (Retrophin, Inc., Filed With SEC on April 20, 2022)

Transition and Retirement Agreement by and between Gerald McMahon and the Registrant, dated as of October 25, 2021 (Harpoon Therapeutics, Inc., Filed With SEC on March 10, 2022)

Third Amendment to the Amgen Inc. Supplemental Retirement Plan, effective October 20, 2021 (Amgen Inc., Filed With SEC on February 16, 2022)

Retirement Agreement (vTv Therapeutics Inc., Filed With SEC on October 20, 2021)

Transition and Retirement Agreement between Brian G. Drazba and MEI Pharma, Inc., dated as of August 2, 2021 (MEI Pharma, Inc., Filed With SEC on August 5, 2021)

Form of Retirement Agreement, by and between Cyclacel Pharmaceuticals, Inc. and Judy H. Chiao, MD (Cyclacel Pharmaceuticals, Inc., Filed With SEC on February 24, 2021)

Biotechnology (20) | Retirement Agreements (20)